Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers

NCT02542813 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Postpartum Hemorrhage

Interventions

DRUG: IM oxytocin 10 IU
DRUG: IH oxytocin 50 mcg
DRUG: IH oxytocin 200 mcg
DRUG: IH oxytocin 400 mcg
DRUG: IH oxytocin 600 mcg
DRUG: Placebo

Sponsor

GlaxoSmithKline